These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24090393)

  • 1. [Comprehensive organoprotection in patients with high cardiovascular risk: the possibility of ramipril from positions of evidence-based medicine].
    Gaĭsenok OV; Marcevich SIu; Belolipetskaia VG
    Kardiologiia; 2013; 53(9):90-4. PubMed ID: 24090393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ramipril.
    Smith WH; Ball SG
    Int J Clin Pract; 2000 May; 54(4):255-60. PubMed ID: 10912316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The reduction of cardiovascular risk with ramipril].
    Vanuzzo D
    Ital Heart J Suppl; 2000 May; 1(5):713-4. PubMed ID: 10834142
    [No Abstract]   [Full Text] [Related]  

  • 4. Ramipril for the prevention and treatment of cardiovascular disease.
    Vuong AD; Annis LG
    Ann Pharmacother; 2003 Mar; 37(3):412-9. PubMed ID: 12639174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ramipril use in Canada: HOPE or HYPE?
    Pilote L
    CMAJ; 2003 Mar; 168(5):568-9. PubMed ID: 12615751
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences with the realisation of innovative study designs using the example of the HOPE-study].
    Rangoonwala B
    Dtsch Med Wochenschr; 2005 Jul; 130 Suppl 2():S82-5. PubMed ID: 15988674
    [No Abstract]   [Full Text] [Related]  

  • 7. More than just hype.
    Fitchett D
    CMAJ; 2003 Jun; 168(13):1646-7; author reply 1647-8. PubMed ID: 12821613
    [No Abstract]   [Full Text] [Related]  

  • 8. More than just hype.
    Yusuf S; Dagenais G
    CMAJ; 2003 Jun; 168(13):1646; author reply 1647-8. PubMed ID: 12821614
    [No Abstract]   [Full Text] [Related]  

  • 9. ONTARGET proves telmisartan efficacy compared to ramipril in cardiovascular protection of patients at high risk and without heart failure.
    Cardiovasc J Afr; 2008; 19(2):108-9; discussion 109-10. PubMed ID: 18516357
    [No Abstract]   [Full Text] [Related]  

  • 10. Lessons from ONTARGET.
    Berlaimont V; Billiouw JM; Brohet C; Dupont AG; Gazagnes MD; Heller F; Krzesinski JM; Missault L; Persu A; Piérard L; Rottiers R; Vanhooren G; Van Mieghem W; Vervaet P; Herman AG
    Acta Clin Belg; 2008; 63(3):142-51. PubMed ID: 18714845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Further options with ramipril. Besides cardio- and nephro-protection diabetes prevention, too?].
    MMW Fortschr Med; 2003 Sep; 145(39):47. PubMed ID: 14649075
    [No Abstract]   [Full Text] [Related]  

  • 12. ACE inhibitors to prevent cardiovascular events in high-risk patients.
    VandeKieft GK
    J Fam Pract; 2000 Apr; 49(4):373-4. PubMed ID: 10778846
    [No Abstract]   [Full Text] [Related]  

  • 13. The HOPE study: comparison with other trials of secondary prevention.
    Otterstad JE; Sleight P
    Eur Heart J; 2001 Aug; 22(15):1307-10. PubMed ID: 11465962
    [No Abstract]   [Full Text] [Related]  

  • 14. Who is fooling us?
    Mourad JJ; Safar ME; O'Rourke MF
    Lancet; 2002 Jul; 360(9326):89. PubMed ID: 12114069
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of ramipril on cardiovascular events in high-risk patients.
    Weinsaft JW
    N Engl J Med; 2000 Jul; 343(1):64; author reply 66. PubMed ID: 10896543
    [No Abstract]   [Full Text] [Related]  

  • 16. [ONTARGET, PROFESS, TRANSCEND large scale studies. AT1 blockers: evidence based advantage, but less than expected].
    Einecke D
    MMW Fortschr Med; 2008 Sep; 150(38):14, 16. PubMed ID: 18983047
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of ramipril on cardiovascular events in high-risk patients.
    O'Rourke MF; Nichols WW
    N Engl J Med; 2000 Jul; 343(1):64-5; author reply 66. PubMed ID: 10896544
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of a converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients].
    Hébert M
    Presse Med; 2000 Apr; 29(14):790-2. PubMed ID: 10816721
    [No Abstract]   [Full Text] [Related]  

  • 19. The renin angiotensin system and cardiovascular disease: hope or hype?
    Williams B
    J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2):142-6. PubMed ID: 11967805
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical evidence from ONTARGET: the value of an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor.
    Sleight P
    J Hypertens Suppl; 2009 Jul; 27(5):S23-9. PubMed ID: 19587551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.